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Dear Editor,
We read the article by Cury et al. titled ‘‘The modified
Hodge test is a useful tool for ruling out Klebsiella
pneumoniae carbapenemase’’ with interest (1). The authors
aimed to evaluate the modified Hodge test (MHT) as a
phenotypic screening test for Klebsiella pneumoniae carbape-
nemase (KPC). They concluded that standardizing MHT
interpretation may improve the specificity of KPC detection.
Additionally, negative test results ruled out 100% of the
isolates harboring Klebsiella pneumoniae carbapenemase-2.
The test may therefore be regarded as a good epidemiolo-
gical tool.
Carbapenemase resistance has become a major problem
around the world. However, the prevalence of carbapene-
mase resistance genes may have epidemiological differences
between different regions, such as BlaKPC in the American
and European zones, NDM in India, and OXA-48 in Turkey
(2). BlaKPC examination in these trials was used to identify
the genotype. Other resistance genes have been neglected.
Thus, we believe that if BlaKPC-negative isolates, as
determined by PCR, were to be tested in the presence of
BlaIMP, BlaNDM, and BlaOXA-48, the significance of the
study would increase.
Molecular detection of the presence of carbapenemases is
the gold standard for diagnosis, but testing performed on a
routine basis is expensive and impractical (2). All carbape-
nemase resistance caused by the resistance genes is
detectable using the MHT, for which the sensitivity and
specificity of the screening is known to be very good (1,2).
However, the weakest aspect of the MHT is specificity. In a
recent study using K. pneumoniae ATCC 700603 as the
indicator strain instead of E. coli ATCC 25922 in a test
procedure, the MHT had 97% sensitivity and 100%
specificity (3). Another study reported a problem with
sensitivity in expressing NDM-1 strains and found that
specificity increased with the addition of ZnSO4 (4).
Therefore, different resistance genes in different bacteria
must be considered when designing a methodology to
increase sensitivity and specificity. We believe that more
studies are needed on this subject.
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